Nextcure Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.60

-0.15 (-8.57%)

As of Jun 30, 10:43 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +2,103.1% upside

Low Target $27.20

Average Target $35.25

High Target $53.45

Current Price $1.60

Current
$1.60

Target
$35.25

$27.20 $35.25 avg $53.45

Scenario Analysis

Bear Case

$27.20

1,600.0%

Low target

Base Case

$35.25

+2,103.1%

Avg target

Bull Case

$53.45

+3,240.6%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$15.74

-89.8% from high

52-Week Low

$1.59

+0.6% from low

Target vs 52W High

$35.25

+124.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%